Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Suvorexant and Sleep/Delirium in ICU Patients

Phase 4

Recruiting

Conditions: Insomnia
Sleep Fragmentation
Postoperative Delirium
Sleep Initiation and Maintenance Disorders

Interventions: Drug: Suvorexant 20 mg
Drug: Placebo oral tablet

First Posted Date: 2019-09-17

Last Posted Date: 2023-11-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 120

Registration Number: NCT04092894

Locations: 🇺🇸
Montefiore Medical Center/Albert Einstein college of Medicine, Bronx, New York, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients

Phase 3

Active, not recruiting

Conditions: Delirium in Old Age
Delirium
Coronary Artery Disease

Interventions: Other: Placebo
Drug: IV acetaminophen

First Posted Date: 2019-09-17

Last Posted Date: 2025-04-06

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 900

Registration Number: NCT04093219

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California Irvine, Irvine, California, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States

and more 7 locations

Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Regular soda
Behavioral: diet soda
Behavioral: Carbonated Water

First Posted Date: 2019-08-07

Last Posted Date: 2020-02-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 5

Registration Number: NCT04048681

Locations: 🇺🇸
Beth Israel Deaconess Medical Center MRI Research Facility, Boston, Massachusetts, United States

Mind Body Therapy for the Treatment of Chronic Pain

Not Applicable

Completed

Conditions: Chronic Pain Syndrome
Chronic Pain

Interventions: Behavioral: Mind Body Intervention 2

First Posted Date: 2019-07-31

Last Posted Date: 2023-01-11

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 35

Registration Number: NCT04039139

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The PATHFINDER Study: A Feasibility Trial

Early Phase 1

Completed

Conditions: Delirium
Coronary Artery Disease

Interventions: Drug: Ropivacaine
Drug: Ketamine
Drug: Remifentanil
Drug: Dexmedetomidine
Drug: Rocuronium
Drug: Propofol
Drug: Sevoflurane
Device: EEG monitoring

First Posted Date: 2019-07-11

Last Posted Date: 2021-01-28

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 22

Registration Number: NCT04016740

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

DAMP-Mediated Innate Immune Failure and Pneumonia After Trauma - the Harvard-Longwood (HALO) Campus Area Consortium

Not Applicable

Terminated

Conditions: Respiratory Failure

Interventions: Other: Normoxia with Normocarbia
Other: Hyperoxia with Normocarbia
Other: Normoxia with Hypercarbia
Other: Hyperoxia with Hypercarbia

First Posted Date: 2019-06-20

Last Posted Date: 2022-03-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 1

Registration Number: NCT03993002

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Avoiding Neuromuscular Blockers to Reduce Complications

Phase 4

Terminated

Conditions: Aspiration Pneumonia
Pneumonitis
Respiratory Failure
Respiratory Infection
Atelectasis
Bronchospasm

Interventions: Drug: Neuromuscular Blocking Agents
Drug: Anesthetic Adjuncts

First Posted Date: 2019-05-24

Last Posted Date: 2023-02-02

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 3

Registration Number: NCT03962725

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Statins In Intracerbral Hemorrhage

Phase 3

Recruiting

Conditions: Intracerebral Hemorrhage

Interventions: Drug: Statins

First Posted Date: 2019-05-03

Last Posted Date: 2024-08-06

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 1456

Registration Number: NCT03936361

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

3D Printer Modified CPAP Mask for Obstructive Sleep Apnea

Not Applicable

Active, not recruiting

Conditions: Obstructive Sleep Apnea

Interventions: Device: Custom CPAP mask

First Posted Date: 2019-04-30

Last Posted Date: 2020-04-17

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT03932383

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Computer Aided Detection of Polyps in the Colon

Not Applicable

Completed

Conditions: Polyp, Adenomatous
Colo-rectal Cancer

Interventions: Device: Computer Aided Diagnostic Software

First Posted Date: 2019-04-24

Last Posted Date: 2021-07-20

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 234

Registration Number: NCT03925337

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy